Carmell Therapeutics Up 48% On Merger With Axolotl Biologix

Shares of Carmell Therapeutics Corporation (CTCX) are up 48% on Thursday after the company announced its merger with Flagstaff-based Axolotl Biologix, a profitable regenerative medicine company.

Related Keywords

, Nasdaq , Carmell Therapeutics Corporation , Flagstaff Based Axolotl Biologix , Initial Equity Value , Milestone Equity Payments , Axolotl Biologix ,